Institution statistics

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - France 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:27
Total Project Funding per Partner:16
Total Number of Projects:35
Networking Rank (Reputation):74
2017
Criterium:Position:
Overall Score:28
Total Project Funding per Partner:14
Total Number of Projects:30
Networking Rank (Reputation):75
2016
Criterium:Position:
Overall Score:28
Total Project Funding per Partner:15
Total Number of Projects:28
Networking Rank (Reputation):60
2015
Criterium:Position:
Overall Score:33
Total Project Funding per Partner:18
Total Number of Projects:26
Networking Rank (Reputation):71
Partner Constancy:100-200
Project Leadership Index:31
2014
Criterium:Position:
Overall Score:43
Total Project Funding per Partner:10
Total Number of Projects:14
Networking Rank (Reputation):47
Partner Constancy:57
Project Leadership Index:47
Diversity Index:200-300
2013
Criterium:Position:
Overall Score:39
Total Project Funding:39
Total Project Funding per Partner:14
Total Number of Projects:22
Partner Constancy:27
Project Leadership Index:8
Diversity Index:46
2012
Criterium:Position:
Overall Score:58
Total Project Funding:34
Total Project Funding per Partner:33
Total Number of Projects:26
Networking Rank (Reputation):69
Networking Rank (Reputation):69
Partner Constancy:19
Project Leadership Index:20
Diversity Index:42
2011
Criterium:Position:
Overall Score:55
Total Project Funding:26
Total Project Funding per Partner:14
Total Number of Projects:22
Networking Rank (Reputation):63
Partner Constancy:45
Project Leadership Index:24
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:15
Total Project Funding:4
Total Project Funding per Partner:10
Total Number of Projects:14
Networking Rank (Reputation):20
Partner Constancy:11
Project Leadership Index:32
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:38
Total Project Funding:36
Total Project Funding per Partner:21
Total Number of Projects:20
Networking Rank (Reputation):56
Partner Constancy:71
Project Leadership Index:15
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:23
Total Project Funding:13
Total Project Funding per Partner:15
Total Number of Projects:13
Networking Rank (Reputation):25
Partner Constancy:38
Project Leadership Index:31
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:13
Total Project Funding:7
Total Project Funding per Partner:16
Total Number of Projects:9
Networking Rank (Reputation):16
Partner Constancy:50
Project Leadership Index:38
Diversity Index:800-900
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 1049
As coordinator: 140
As participant: 737
Sole participant: 172
Coordinator / Participant Ratio: 0.19*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 42.020.841 55.217.431 16.567.189 6 6
2019 115.545.675 261.728.042 46.484.791 18 31
2018 53.216.669 313.927.876 36.156.209 18 18
2017 4.854.278 166.913.136 38.217.588 9 34
2016 48.266.214 213.530.283 39.973.716 15 34
2015 27.702.573 192.443.155 36.435.884 18 37
2014 10.795.578 90.666.437 39.152.636 15 29
2013 52.316.255 220.673.785 44.851.352 21 39
2012 16.730.877 147.621.637 20.516.387 19 32
2011 27.629.164 189.912.427 31.850.509 21 38
2010 47.402.388 324.065.875 44.130.625 24 56
2009 22.761.549 118.922.565 18.743.039 18 32
2008 51.721.002 287.234.803 26.531.186 22 51
2007 11.295.366 128.443.407 8.743.079 10 27
2006 18.028.049 252.864.960 14.205.604 14 43
2005 30.147.418 241.155.808 15.946.181 17 42
2004 43.621.586 322.352.767 18.699.661 12 48
2003 174.980 26.139.285 1.888.788 1 11
2002 10.694.440 117.230.929 13.216.874 9 56
2001 12.509.334 45.706.385 8.269.001 12 29
2000 9.810.097 98.216.409 12.965.439 13 44
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE166
KAROLINSKA INSTITUTE123
UNIVERSITY COLLEGE LONDON119
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD85
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE80
INSERM TRANSFERT74
KING'S COLLEGE LONDON72
KATHOLIEKE UNIVERSITEIT LEUVEN69
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE66
CHARITE UNIVERSITAETSMEDIZIN BERLIN63
MEDICAL RESEARCH COUNCIL63
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM52
STICHTING KATHOLIEKE UNIVERSITEIT51
UPPSALA UNIVERSITET51
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS50
EUROPEAN MOLECULAR BIOLOGY LABORATORY49
INSTITUT PASTEUR49
COMMISSARIAT A L'ENERGIE ATOMIQUE48
MEDIZINISCHE UNIVERSITAET WIEN42
LEIDEN UNIVERSITY MEDICAL CENTER40
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT39
ISTITUTO SUPERIORE DI SANITA39
UNIVERSITY OF NEWCASTLE UPON TYNE39
THE UNIVERSITY OF EDINBURGH38
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS37
CONSIGLIO NAZIONALE DELLE RICERCHE37
THE UNIVERSITY OF MANCHESTER37
UNIVERSITE DE GENEVE37
UNIVERSITY OF COPENHAGEN37
UNIVERSITY OF HELSINKI36
LUNDS UNIVERSITET35
UNIVERSITAETSKLINIKUM FREIBURG34
UNIVERSITY OF GLASGOW34
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV33
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR32
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN32
UNIVERSITAETSKLINIKUM HEIDELBERG32
EBERHARD KARLS UNIVERSITAET TUEBINGEN31
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE31
UNIVERSITAIR MEDISCH CENTRUM UTRECHT31
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM30
ACADEMISCH ZIEKENHUIS GRONINGEN30
MEDIZINISCHE HOCHSCHULE HANNOVER29
UNIVERSITE CATHOLIQUE DE LOUVAIN28
UNIVERSITA DEGLI STUDI DI MILANO27
UNIVERSITE LIBRE DE BRUXELLES27
UNIVERSITAET ULM26
UNIVERSITA DEGLI STUDI DI PADOVA25
WEIZMANN INSTITUTE OF SCIENCE25
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH24
UNIVERSITE DE LIEGE24
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI24
UNIVERSITEIT MAASTRICHT24
UNIVERSITY OF DUNDEE24
DEUTSCHES KREBSFORSCHUNGSZENTRUM23
INSTITUTO DE SALUD CARLOS III23
UNIVERSITEIT GENT23
REGION HOVEDSTADEN22
UNIVERSITAET ZUERICH22
UNIVERSITEIT UTRECHT22
UNIVERSITY OF LEICESTER22
GOETEBORGS UNIVERSITET21
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI21
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV21
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON21
TARTU ULIKOOL21
TECHNISCHE UNIVERSITAET DRESDEN21
THE UNIVERSITY OF LIVERPOOL21
UNIVERSITY OF BIRMINGHAM21
UNIVERSITY OF SOUTHAMPTON21
UNIVERSITY OF WALES CARDIFF21
ACADEMISCH ZIEKENHUIS LEIDEN20
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER20
GENOME RESEARCH20
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE20
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS20
SERVICIO MADRILENO DE SALUD20
THE UNIVERSITY OF SHEFFIELD20
KAROLINSKA INSTITUTET19
UNIVERSITA DEGLI STUDI DI TORINO19
UNIVERSITY OF BRISTOL19
UNIVERSITY OF LEEDS19
HEINRICHHEINEUNIVERSITAET DUESSELDORF18
LEIDEN UNIVERSITY18
RUPRECHT KARLS UNIVERSITAET HEIDELBERG18
TEL AVIV UNIVERSITY18
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA18
UNIVERSITAET BERN18
VRIJE UNIVERSITEIT BRUSSEL18
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS17
ST GEORGE'S HOSPITAL MEDICAL SCHOOL17
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS17
UNIVERSITY OF OSLO17
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM16
ALBERT LUDWIGS UNIVERSITAET FREIBURG16
NATIONAL UNIVERSITY OF IRELAND GALWAY16
OSPEDALE PEDIATRICO BAMBINO GESU16
PHILIPPS UNIVERSITAET MARBURG16
UNIVERSITAT AUTONOMA DE BARCELONA16
UNIVERSITY OF AARHUS16
Constancy:

Total number of partners:11468

Partner loyalty:
Frequent Partner: (> 2 projects): 7464
Rare Partner: 4004

Frequent / Rare Partner Ratio: 1.86

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES577
RTD HORIZONTAL TOPICS389
SOCIAL AND ECONOMIC CONCERNS222
PROTECTING MAN AND HIS ENVIRON93
INDUSTRY AND TECHNOLOGY60
AGRICULTURE AND MARINE RESOURC21
ENERGY6
PHYSICAL AND EXACT SCIENCES3
MEASUREMENTS AND STANDARDS3

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases LONGITOOLSparticipant11.997.44918
2020-01-01Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy CANDYparticipant6.000.00016
2020-01-01FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA FAIRcoordinator10.162.90411
2020-01-01EXposome Powered tools for healthy living in urbAN SEttings EXPANSEparticipant11.993.90720
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84810
2020-01-01Visualizing Death Inducing Protein Complexes VIDECparticipant1.237.40010
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAcoordinator4.822.1979
2020-01-01Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility miniNOcoordinator6.487.77010
2020-01-01Personalized Prevention for Coronary Heart Disease CoroPreventionparticipant19.970.827
2020-01-01Deconstructing the role of SUMO on chromatin in cell identity and tissue repair SUMiDENTITYcoordinator2.499.9951
2020-01-01Gene Therapy to restore lymphatic flow lymphedema TheraLymphcoordinator8.064.94611
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bcoordinator9.983.02914
2019-12-01COmplement Regulation and Variations in Opportunistic infectionS CORVOSparticipant4.088.95110
2019-11-01Secretion, Autophagy and their role in Neurodegeneration SANDparticipant4.156.40513
2019-11-01Metabolic integration by nutrient SENSing MetaboSENScoordinator1.999.3911
2019-10-01A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) HEPCANcoordinator150.0001
2019-10-01The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance proEVLifeCycleparticipant2.672.56210
2019-10-01A nanovaccine Approach for the treatment of Pancreatic Cancer PAVEparticipant4.023.61713
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19269
2019-07-01NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW GNA NOWparticipant12.299.99511
2019-07-01Coordination and Harmonisation of National Inititiatives, Infrastructures and Data services in Central and Western Europe EOSC-Pillarparticipant6.880.96518
2019-07-01Targeting endothelial barriers to combat disease BreakingBarrierscoordinator2.499.9691
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTcoordinator3.429.2176
2019-06-01Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs HARMONICparticipant6.999.98924
2019-06-01AGE-RELATED CHANGES IN HEMATOPOIESIS ARCHparticipant3.969.93619
2019-06-01Regulation of synaptic development and plasticity by molecular pathways linked to human evolution SYNPATHcoordinator1.500.0001
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-05-01Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease MechanoMVPcoordinator196.7081
2019-04-01Mass-transfer independent long-term implantable biosensors ImplantSensparticipant3.006.10616
2019-04-01HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY PML-THERAPYcoordinator2.500.0002
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99151
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMcoordinator6.700.00021
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00010
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Providing an open collaborative space for digital biology in Europe EOSC-Lifeparticipant23.745.99646
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-03-01Well-Aging and the Tanycytic Control of Health WATCHcoordinator9.866.2503
2019-02-01European Advanced infraStructure for Innovative Genomics EASI-Genomicsparticipant9.991.26716
2019-01-15Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory CentralNervous System lesion size and severity through Gas1 co-receptor modulation. EFHHBBBMScoordinator173.0761
2019-01-01Advancing European Research Infrastcuture on Highly Pathogenic Agents ERINHA-Advanceparticipant3.246.80511
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2019-01-01The role of GABAergic circuits in the orchestration of hippocampal neuronal assemblies GABASSEMBLYcoordinator173.0761
2019-01-01ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) JPCOFUND2coordinator11.010.91129
2019-01-01Biomechanics in health and disease: advanced physical tools for innovative early diagnosis Phys2BioMedparticipant3.911.78316
2019-01-01Induced pluripotent stem cell-based therapy for spinal regeneration iPSpineparticipant14.959.78120
2019-01-01Genome, Environment, Microbiome & Metabolome in Autism: an integrated multi-omic systems biology approach to identify biomarkers for personalized treatment and primary prevention of Autism Spectr GEMMAparticipant14.225.75816
2019-01-01Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach FREIAparticipant6.104.47611
2019-01-01Exploring and Modifying the Sense of Time in Virtual Environments VIRTUALTIMESparticipant4.404.6996
2019-01-01European Joint Programme on Rare Diseases EJP RDcoordinator55.073.83188
2019-01-01Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. ONCOBIOMEparticipant14.994.55118

overview shows latest 50 from 1049 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE UNITE DE RECHERCHE 515 HOPITAL SAINTANTOINE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum